KSC:005690

Pharmicell Co., Ltd. · KSC · Healthcare · KRW · FY for 2025

Figures on this page computed 2026-11-08 13:22 UTC

Last close

n/aKRW

Market data

11.8xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
KRW
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
35.4%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
29.5%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
0.12Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
KRW
- computed

6 of 6 traits placed on the market's range. Nothing sits below its sector's middle.

Follow one won

lens 1 of 9

After what it costs to make

43.9%

After running the business

29.6%

After interest and tax

35.4%

After what it must reinvest

29.5%

Kept after the dividend

28.4%

after what it costs to make, 43.9% of sales; after running the business, 29.6% of sales; after interest and tax, 35.4% of sales; after what it must reinvest, 29.5% of sales; kept after the dividend, 28.4% of sales

The five stops

5 of 5 read

After what it costs to make50,014,763,00043.9%
After running the business33,776,034,00029.6%
After interest and tax40,329,514,00035.4%
After what it must reinvest33,601,600,00029.5%
Kept after the dividend32,401,520,00028.4%

Of every unit of sales, 0.28 is still there after the dividend.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales114,061,538,000
Source
computed
Statement
income
Fiscal year
2025
Reported in
KRW
After what it costs to make50,014,763,000
Source
computed
Statement
income
Fiscal year
2025
Reported in
KRW
After running the business33,776,034,000
Source
computed
Statement
income
Fiscal year
2025
Reported in
KRW
After interest and tax40,329,514,000
Source
computed
Statement
income
Fiscal year
2025
Reported in
KRW
After what it must reinvest33,601,600,000
Source
computed
Statement
income
Fiscal year
2025
Reported in
KRW
Kept after the dividend32,401,520,000
Source
computed
Statement
income
Fiscal year
2025
Reported in
KRW